Currently, Christopher Ross is Chief Financial Officer for Telo Genomics Corp. and Chief Financial Officer at Intertidal Capital Corp. Mr. Ross is also Member of Chartered Professional Accountants of Canada and Principle at Modum Corporate Services, Inc.

He previously held the position of Chief Financial Officer for XPhyto Therapeutics Corp. and Controller of Nicola Mining, Inc.

Christopher Ross received an undergraduate degree from the University of British Columbia.